Strong and healthy muscles are a key factor in mobility, quality of life and healthy aging. But while many processes in the human body can now be measured precisely, muscles often remain a black box. Munich-based medtech startup Noxon wants to change that – and has secured several million euros in seed financing to further develop its technology.
The round is led by High-Tech Gründerfonds. Bayern Kapital, Auxxo and another institutional investor are also participating. The financing was arranged with the support of the BayStartUP investor network.
BayStartUP Managing Director Dr. Carsten Rudolph says:
„Noxon's young founding team combines exceptional interdisciplinary expertise – from neuroscience and medical technology to hardware, software and AI-based signal processing. We have been supporting the company since its early days and are impressed by how consistently this expertise has been translated into a marketable product, resulting in the rapid formation of a strong team of experienced industry experts.“
This example shows how important structured preparation and access to suitable investors are for technology-driven start-ups – especially in capital-intensive areas such as medtech.
DeepTech from Bavaria with an international perspective
Noxon is a prime example of technology-driven start-ups from Bavaria that combine scientific excellence with entrepreneurial scaling. With the current seed financing, the company is taking the decisive step from research to clinical application and market entry.
Are you planning a seed or Series A round yourself?
Your next steps:
Check:
- Is your business model clearly validated?
- Are regulatory requirements strategically planned?
- Is your pitch ready for investors?
- Do you know the right investors for your phase?
Next Step:
Take advantage of our coaching services or apply for the Bavarian Business Plan Competitions. We provide structured support on your path to successful financing.